Publications by authors named "Bhash Naidoo"

Claim this Profile
T
The EQ-HWB: Overview of the Development of a Measure of Health and Wellbeing and Key Results.
John Brazier, Tessa Peasgood, Clara Mukuria, Ole Marten, Simone Kreimeier, Bhash Naidoo

Value Health· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the development of the EQ-HWB?
Tessa Peasgood, Clara Mukuria, Jill Carlton, Janice Connell, Nancy Devlin, Bhash Naidoo

Eur J Health Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging DICE (Discretely-Integrated Condition Event) Simulation to Simplify the Design and Implementation of Hybrid Models.
J Jaime Caro, Ross Maconachie, Michael Woods, Bhash Naidoo, Alistair McGuire

Value Health· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A threshold analysis assessed the credibility of conclusions from network meta-analysis.
Deborah M Caldwell, A E Ades, Sofia Dias, Sarah Watkins, Tianjing Li, Bhash Naidoo

J Clin Epidemiol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence informed decision making: the use of "colloquial evidence" at nice.
Tarang Sharma, Moni Choudhury, Bindweep Kaur, Bhash Naidoo, Sarah Garner

Int J Technol Assess Health Care· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Japanese Cancer Association Meeting UICC International session--what is cost-effectiveness in cancer treatment?
Hideyuki Akaza, Norie Kawahara, Jae Kyung Roh, Hajime Inoue, Eun-Cheol Park, Bhash Naidoo

Asian Pac J Cancer Prev· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NICE guidance on pirfenidone for treating idiopathic pulmonary fibrosis.
Linda J Landells, Bhash Naidoo, Janet Robertson, Peter Clark

Lancet Respir Med· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should we invest in environmental interventions to encourage physical activity in England? An economic appraisal.
Sophie J Beale, Matthew W Bending, Paul Trueman, Bhash Naidoo

Eur J Public Health· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NICE guidance on erlotinib for first-line treatment of EGFR-TK mutation-positive advanced or metastatic non-small-cell lung cancer.
Bernice Dillon, Bhash Naidoo, Helen Knight, Peter Clark

Lancet Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effective public health guidance: asking questions from the decision-maker's viewpoint.
Kalipso Chalkidou, Anthony Culyer, Bhash Naidoo, Peter Littlejohns

Health Econ· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of a simulation model of primary prevention strategies for coronary heart disease.
Hannah Babad, Colin Sanderson, Bhash Naidoo, Ian White, Duolao Wang

Health Care Manag Sci· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis